LABA and LAMA are used to relieve the symptoms of ... AstraZeneca), which are ICS–LABA combinations, are other popular COPD drugs. A major limitation with the current corticosteroid therapy ...

and a long-acting muscarinic antagonist (LAMA) in a single delivery device, in an extra-fine formulation. The drug is likely to be the first COPD triple therapy on the market, after Europe’s ...

and 'triple therapy' combining LAMA + LABA + ICS. Current rescue drugs for COPD include SABA, SAMA, systemic corticosteroids and antibiotics. Combining different forms of NRT or simultaneously ...

“The exciting news is that there is a drug that looks like it will work for COPD, and that may soon have ... a long-acting ...

The CRYSTAL study is the first LABA/LAMA pragmatic ... from other COPD treatments, such as inhaled steroid-containing combination therapies," said Vasant Narasimhan, Global Head Drug Development ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...